Gemcitabine resistance in pancreatic cancer: picking the key players
- PMID: 18316544
- DOI: 10.1158/1078-0432.CCR-07-2247
Gemcitabine resistance in pancreatic cancer: picking the key players
Comment on
-
HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.Clin Cancer Res. 2008 Mar 1;14(5):1470-7. doi: 10.1158/1078-0432.CCR-07-1450. Clin Cancer Res. 2008. PMID: 18316571 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical